Allogeneic hematopoietic cell transplantation in systemic mastocytosis: is there a high risk for veno-occlusive disease?

Eur J Haematol. 2016 Jun;96(6):655-7. doi: 10.1111/ejh.12720. Epub 2016 Jan 22.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Hematopoietic Stem Cell Transplantation / adverse effects*
  • Hepatic Veno-Occlusive Disease / diagnostic imaging
  • Hepatic Veno-Occlusive Disease / drug therapy
  • Hepatic Veno-Occlusive Disease / etiology
  • Humans
  • Male
  • Mastocytosis, Systemic / complications*
  • Mastocytosis, Systemic / therapy
  • Middle Aged
  • Platelet Aggregation Inhibitors / therapeutic use
  • Polydeoxyribonucleotides / therapeutic use
  • Pulmonary Veno-Occlusive Disease / diagnostic imaging
  • Pulmonary Veno-Occlusive Disease / drug therapy
  • Pulmonary Veno-Occlusive Disease / etiology
  • Transplantation Conditioning / adverse effects
  • Transplantation Conditioning / methods
  • Transplantation, Homologous
  • Treatment Outcome
  • Vascular Diseases / diagnosis*
  • Vascular Diseases / drug therapy
  • Vascular Diseases / etiology*

Substances

  • Platelet Aggregation Inhibitors
  • Polydeoxyribonucleotides
  • defibrotide